Effect of cyclooxygenase and nitric oxide synthase inhibitors on vincristine induced hyperalgesia in rats

Pharmacological Reports

Volumn 60, Issue 5, 2008, Pages 735-741

  Bujalska, Magdalena ^a   Gumułka, Stanisław W ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Celecoxib; Cyclooxygenase; Hyperalgesia; Indomethacin; Nitric oxide inhibitors; Rats; Vincristine

Indexed keywords

7 NITROINDAZOLE; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE; N6 (1 IMINOETHYL)LYSINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HYPERALGESIA; NEUROMUSCULAR TRANSMISSION; NEUROPROTECTION; NONHUMAN; PAIN; PAIN THRESHOLD; RAT; STIMULUS RESPONSE;

EID: 57849114808     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Aley KO, Levine JD: Different peripheral mechanisms mediate enhanced nocicepton in metabolic/toxic and traumatic painful peripheral neuropathies in the rat. Neuroscience, 2002, 111, 389-397.
2. Aley KO, Reichling DB, Levine JD: Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience, 1996, 73, 259-265.
3. Bujalska M, Tatarkiewicz J, deCordé A, Gumułka SW: Effect of cyclooxygenase and nitric oxide synthase inhibitors on streptozotocin-induced hyperalgesia in rats. Pharmacology, 2008, 81, 151-157.
4. Bujalska M, Tatarkiewicz J, Gumułka SW: Effect of bradykinin receptors antagonists on vincristine and streptozotocin induced hyperalgesia in rat model of chemotherapy-induced and diabetic neuropathy. Pharmacology, 2008, 81, 158-163.
5. Cata JP, Weng HR, Dougherty PM: Cyclooxygenase inhibitors and thalidomide ameliorate vincristine-induced hyperalgesia in rats. Cancer Chemother Pharmacol, 2004, 54, 391-397.
6. Choi Y, Raja SN, Moore LC, Tobin JR: Neuropathic pain in rats is associated with altered nitric oxide synthase activity in neural tissue. J Neurol Sci, 1996, 138, 14-20.
7. Durrenberger PF, Facer P, Casula MA, Yiangou Y, Gray RA, Chessell IP, Day NC et al.: Prostanoid receptor EP1 and Cox-2 in injured human nerves and a rat model of nerve injury: a time-course study. BMC Neurol, 2006, 6, 1-11.
8. Guan Y, Yaster M, Raja SN, Tao YX: Genetic knockout and pharmacologic inhibition of neuronal nitric oxide synthase attenuate nerve injury-induced mechanical hypersensitivity in mice. Mol Pain, 2007, 3, 1-10.
9. Hao JX, Xu XJ: Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered nitric oxide synthase inhibitors. Pain, 1996, 66, 313-319.
10. Hefferan MP, O'Rielly DD, Loomis CW: Inhibition of spinal prostaglandin synthesis early after L5/L6 nerve ligation prevents the development of prostaglandin-dependent and prostaglandin-independent allodynia in the rat. Anesthesiology, 2003, 99, 1180-1188.
11. Inoue T, Mashimo T, Shibata M, Shibuta S, Yoshiya I: Rapid development of nitric oxide-induced by oralgesia depends on an alternate to the cGMP-mediated, pathway in the rat neuropathic pain model. Brain Res, 1998, 792, 263-270.
12. Kamei J, Tamura N, Saitoh A: Possible involvement of the spinal nitric oxide/cGMP pathway in vincristine-induced painful neuropathy in mice. Pain, 2005, 117, 112-120.
13. Levy D, Höke A, Zochodne DW: Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain. Neurosci Lett, 1999, 260, 207-209.
14. Levy D, Kubes P, Zochodne DW: Delayed peripheral nerve degeneration, regeneration, and pain in mice lacking inducible nitric oxide synthase. Neuropathol Exp Neurol 2001, 60, 411-421.
15. Levy D, Zochodne DW: Local nitric oxide synthase activity in a model of neuropathic pain. Eur J Neurosci, 1998, 10, 1846-1855.
16. Lui PW, Lee CH:. Preemptive effects of intrathecal cyclooxygenase inhibitor or nitric oxide synthase inhibitor on thermal hypersensitivity following peripheral nerve injury. Life Sci, 2004, 75, 2527-2538.
17. Ma W, Du W, Eisenach JC: Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Brain Res, 2002, 937, 94-99.
18. Ma W, Eisenach JC: Cyclooxygenase 2 in infiltrating inflammatory cells in injured nerve is universally upregulated following various types of peripheral nerve injury. Neuroscience, 2003, 121, 691-704.
19. Ma W, Eisenach JC: Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain. Eur J Neurosci, 2002, 15, 1037-1047.
20. Moalem G, Tracey DJ: Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev, 2006, 51, 240-264.
21. Naik AK, Tandan SK, Kumar D, Dudhgaonkar SP: Nitric oxide and its modulators in chronic constriction injury-induced neuropathic pain in rats. Eur J Pharmacol, 2006, 530, 59-69.
22. Niedbala B, Sánchez A, Feria M: Nitric oxide mediates neuropathic pain behavior in peripherally denervated rats. Neurosci Lett, 1995, 188, 57-60.
23. 2 in the rat lumbar spinal cord 3 days after L5-L6 spinal nerve ligation. Anesthesiology, 2006, 104, 328-337.
24. Randall LO, Selitto JJ: A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther, 1957, 111, 409-419.
25. Sousa AM, Prado WA: The dual effect of a nitric oxide donor in nociception. Brain Res, 2001, 897, 9-19.
26. Suleyman H, Dermican B, Karagöz Y: Anti-inflammatory and side effects of cyclooxygenase inhibitors. Pharmacol Rep, 2007, 59, 247-258.
27. Syriatowicz JP, Hu D, Walker JS, Tracey DJ: Hyperalgesia due to nerve injury: role of prostaglandins. Neuroscience, 1999, 94, 587-594.
28. Takahashi M, Kawaguchi M, Shimada K, Konishi N, Furuya H, Nakashima T: Cyclooxygenase-2 expression in Schwann cells and macrophages in the sciatic nerve after single spinal nerve injury in rats. Neurosci Lett, 2004, 363, 203-206.
29. Tallarida RJ, Murray RB: Manual of Pharmacologic Calculation with Computer Programs, 2nd edn., New York, Springer, 1986, 113-117.
30. Tanner KD, Levine JD, Topp KS: Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat. J Comp Neurol, 1998, 395, 481-492.
31. Topp KS, Tanner KD, Levine JD: Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat. J Comp Neurol, 2000, 424, 563-576.
32. Verge VM, Xu Z, Xu XJ, Wiesenfeld-Hallin Z, Hökfelt T: Marked increase in nitric oxide synthase mRNA in rat dorsal root ganglia after peripheral axotomy: in situ hybridization and functional studies. Proc Natl Acad Sci U S A, 1992, 89, 11617-11621.
33. Willingale HL, Gardiner NJ, McLymont N, Giblett S, Grubb BD: Prostanoids synthesized by cyclo-oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability. Br J Pharmacol, 1997, 122, 1593-1604.
34. Yoon YW, Sung B, Chung JM: Nitric oxide mediates behavioral signs, of neuropathic pain in an experimental rat model. Neuroreport, 1998, 9, 367-372.
35. Zhu X, Eisenach JC: Cyclooxygenase-1 in the spinal cord is altered after peripheral nerve injury. Anesthesiology, 2003, 99, 1175-1179.